<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: signal transduction</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study confirms everolimus can overcome trastuzumab resistance in HER-2 positive early breast cancer</title>
   	 <description>A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.</description>
	  <link>http://medicalxpress.com/news/2013-05-everolimus-trastuzumab-resistance-her-positive.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 May 2013 10:35:22 EST</pubDate>
	 <guid isPermaLink="false">news286709710</guid>
	 
</item>
<item>
     <title>Novel AKT pathway inhibitor, ARQ 092, demonstrated safety, effective target inhibition</title>
   	 <description>Researchers have confirmed that the novel oral agent ARQ 092 inhibits the AKT pathway and has a manageable safety profile in patients with a variety of advanced solid tumors, according to phase I data presented at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10.</description>
	  <link>http://medicalxpress.com/news/2013-04-akt-pathway-inhibitor-arq-safety.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 09 Apr 2013 07:21:37 EST</pubDate>
	 <guid isPermaLink="false">news284710890</guid>
	 
</item>
<item>
     <title>Parkinson's disease: Parkin protects from neuronal cell death</title>
   	 <description>Researchers from Ludwig-Maximilians-Universitaet (LMU) in Munich identify a novel signal transduction pathway, which activates the parkin gene and prevents stress-induced neuronal cell death.</description>
	  <link>http://medicalxpress.com/news/2013-03-parkinson-disease-parkin-neuronal-cell.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Fri, 01 Mar 2013 11:07:03 EST</pubDate>
	 <guid isPermaLink="false">news281358185</guid>
	 
</item>
<item>
     <title>Enzyme offers new therapeutic target for cancer drugs</title>
   	 <description>Researchers at the University of California, San Diego School of Medicine have uncovered a new signal transduction pathway specifically devoted to the regulation of alternative RNA splicing, a process that allows a single gene to produce or code multiple types of protein variants. The discovery, published in the June 27, 2012 issue of Molecular Cell, suggests the new pathway might be a fruitful target for new cancer drugs.</description>
	  <link>http://medicalxpress.com/news/2012-06-enzyme-therapeutic-cancer-drugs.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 21 Jun 2012 13:20:18 EST</pubDate>
	 <guid isPermaLink="false">news259497122</guid>
	 
</item>
<item>
     <title>Researchers create new anti-cancer drug</title>
   	 <description>A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers.</description>
	  <link>http://medicalxpress.com/news/2012-05-anti-cancer-drug.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 22 May 2012 09:58:33 EST</pubDate>
	 <guid isPermaLink="false">news256899505</guid>
	 
</item>
<item>
     <title>Chronic exposure to methyl-mercury increases of neurodegenerative disease</title>
   	 <description>The research team led by Prof. Samuel Lo, Associate Head of the Department of Applied Biology and Chemical Technology, recently discovered that chronic exposure to low-dose methyl-mercury, an environmental contaminant commonly found in seafood, may increase the risk of developing neurodegenerative disease.</description>
	  <link>http://medicalxpress.com/news/2011-08-chronic-exposure-methyl-mercury-neurodegenerative-disease.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 04 Aug 2011 07:00:01 EST</pubDate>
	 <guid isPermaLink="false">news231658411</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/chronicexpos.jpg" width="90" height="90" />
</item>
<item>
     <title>Exposing the potential of sugar chains for the diagnosis and treatment of disease</title>
   	 <description>Protruding from the surface of cells in the body like whiskers are sugar chains, a biological structure often bound to lipids and proteins embedded in the cell membrane. Recent studies have shown that sugar chains exhibit a broad range of functions, including signal transduction between cells and across the cell membrane, as well as functional regulation of immunity and hormones. &amp;#147;From among the diverse functions of sugar chains, we focus on their association with disease,&amp;#148; says Naoyuki Taniguchi, group director of the Systems Glycobiology Research Group at the RIKEN Advanced Science Institute and a world-renowned researcher in sugar chains. &amp;#147;The ultimate goal of our research is to clarify the mechanisms of the onset of disease in terms of sugar chains, and to diagnose and treat disease using those mechanisms.&amp;#148; Taniguchi&amp;#146;s research is probing the frontiers of sugar chain science for the diagnosis and treatment of disease.</description>
	  <link>http://medicalxpress.com/news/2011-06-exposing-potential-sugar-chains-diagnosis.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 20 Jun 2011 09:35:50 EST</pubDate>
	 <guid isPermaLink="false">news227781339</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/exposingthep.jpg" width="90" height="90" />
</item>


</channel>
</rss>
